End-of-day quote
Shanghai S.E.
18:00:00 2024-05-09 EDT
|
5-day change
|
1st Jan Change
|
21.92
CNY
|
-4.40%
|
|
+1.91%
|
-20.06%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
31,940
|
20,872
|
11,073
|
8,852
|
-
|
Enterprise Value (EV)
1 |
31,940
|
20,872
|
11,073
|
8,852
|
8,852
|
P/E ratio
|
160
x
|
75.6
x
|
161
x
|
78.3
x
|
48.7
x
|
Yield
|
0.09%
|
0.2%
|
0.18%
|
-
|
-
|
Capitalization / Revenue
|
71.6
x
|
29.6
x
|
18.9
x
|
10.5
x
|
8
x
|
EV / Revenue
|
71.6
x
|
29.6
x
|
18.9
x
|
10.5
x
|
8
x
|
EV / EBITDA
|
111
x
|
61.6
x
|
98.6
x
|
50.6
x
|
32.5
x
|
EV / FCF
|
289,393,115
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
0%
|
-
|
-
|
-
|
-
|
Price to Book
|
30.6
x
|
13.5
x
|
6.5
x
|
5.18
x
|
4.67
x
|
Nbr of stocks (in thousands)
|
400,146
|
403,172
|
403,815
|
403,815
|
-
|
Reference price
2 |
79.82
|
51.77
|
27.42
|
21.92
|
21.92
|
Announcement Date
|
22-02-25
|
23-02-27
|
24-02-29
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
446.3
|
705.8
|
586.9
|
847
|
1,106
|
EBITDA
1 |
-
|
288.6
|
338.8
|
112.4
|
175
|
272
|
EBIT
1 |
-
|
212.9
|
306.2
|
65.2
|
133
|
217
|
Operating Margin
|
-
|
47.69%
|
43.38%
|
11.11%
|
15.7%
|
19.62%
|
Earnings before Tax (EBT)
1 |
-
|
212.8
|
307.2
|
65.36
|
132
|
217
|
Net income
1 |
72.69
|
188.1
|
275.1
|
68.57
|
112
|
184
|
Net margin
|
-
|
42.14%
|
38.98%
|
11.68%
|
13.22%
|
16.64%
|
EPS
2 |
0.2041
|
0.4974
|
0.6844
|
0.1699
|
0.2800
|
0.4500
|
Free Cash Flow
|
-
|
110.4
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
24.73%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
38.25%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
58.68%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.0710
|
0.1030
|
0.0500
|
-
|
-
|
Announcement Date
|
21-06-02
|
22-02-25
|
23-02-27
|
24-02-29
|
-
|
-
|
Fiscal Period: December |
2022 Q1
|
---|
Net sales
1 |
140.9
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
60.92
|
Net margin
|
43.25%
|
EPS
|
-
|
Dividend per Share
|
-
|
Announcement Date
|
22-07-13
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
110
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
23.8%
|
21.6%
|
4.23%
|
6.5%
|
9.7%
|
ROA (Net income/ Total Assets)
|
-
|
19.6%
|
17%
|
-
|
4.7%
|
6.7%
|
Assets
1 |
-
|
959.7
|
1,616
|
-
|
2,383
|
2,746
|
Book Value Per Share
2 |
-
|
2.600
|
3.830
|
4.220
|
4.230
|
4.690
|
Cash Flow per Share
2 |
-
|
0.3900
|
0.2800
|
0.3100
|
0.3500
|
0.5100
|
Capex
1 |
-
|
47.2
|
155
|
94.1
|
75
|
91
|
Capex / Sales
|
-
|
10.57%
|
21.95%
|
16.04%
|
8.85%
|
8.23%
|
Announcement Date
|
21-06-02
|
22-02-25
|
23-02-27
|
24-02-29
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -20.06% | 1.28B | | +5.97% | 105B | | -4.19% | 63.99B | | +51.90% | 43.02B | | +17.44% | 39.28B | | +6.78% | 33.09B | | +12.77% | 20.23B | | +15.64% | 17.39B | | +22.55% | 15.45B | | +7.34% | 15.07B |
Other Commodity Chemicals
|